Mouna Sassi: Viscoelastic Evidence of Altered Clot Stability in Pediatric Edoxaban Overdose
Mouna Sassi, Head of Laboratory Department at Monastir Maternity Center, Assistant in Hematology at Monastir Hospital–University, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in TH Open, adding:
“Edoxaban.
Our case confirms that accidental Edoxaban overdose in a healthy child can remain clinically silent with rapid normalization of coagulation tests.
Beyond the benign clinical course, the key finding is the reproducible pattern of increased clot lysis on viscoelastic testing, mimicking FXIII functional impairment despite negligible anti-Xa activity.
This observation suggests a potential indirect effect of edoxaban on clot stabilization at low plasma levels.
Further studies are needed to clarify this mechanism and determine its relevance in pediatric anticoagulation monitoring.”
Title: Edoxaban Overdose in a Child: Unexpected Observation of Clot Lysis
Authors: Mouna Sassi, Emna Sfar, Linda Khefacha, Nouha Berrayana, Radhia Haj Salem, Slaheddine Chouchane

Stay updated on all scientific advances Hemostasis Today.
-
Jun 14, 2026, 22:49Cihan Ay: From First Oral Presentation to Pro and Con Debate – A 20-Year EHA Journey
-
Jun 14, 2026, 19:54Tareq Abadl: What Happens If You Transfuse the Wrong Blood Group?
-
Jun 14, 2026, 19:46Amber Yates: Stretching Scientific Muscles in Areas of Hematology – Day 2 at EHA 2026
-
Jun 14, 2026, 19:41Peter Loffelhardt: Thousands of People Coming in – Second Day at EHA 2026
-
Jun 14, 2026, 19:38Jecko Thachil: Can We Predict and Prevent Bleeding in APL?
-
Jun 14, 2026, 19:32Highlights from Day 1 at the EHC Leadership Conference 2026
-
Jun 14, 2026, 18:01Ahmar U. Zaidi: The First Pivotal Study of a New Mechanism in Sickle Cell Disease
-
Jun 14, 2026, 18:00Lennart Lenk: Witnessing Former Boss Deliver a Plenary Talk at EHA 2026
-
Jun 14, 2026, 18:00Priya Sriskandarajah: Great Presentations on Recent Advances in Myelofibrosis at EHA 2026